CMS Open Payments · Program Year 2024
Visby Medical, Inc.
Visby Medical, Inc. reported $3,036,090.32 across General Payments, Research, and Ownership to 30 physicians and teaching hospitals across 187 transactions.
- $3.0M Top quartile payer
- All-tracks total
- 187 Above-median volume
- Transactions
- 30 Below-median reach
- Recipients
- +$2.6K
- General Payments vs PY2023
Visby Medical, Inc. reported $3,036,090.32 across all CMS Open Payments tracks (General + Research + Ownership) to 30 physicians and teaching hospitals in Program Year 2024 - ranking #359 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $73,418.24, averaging $101.2K per recipient.
How Visby Medical, Inc.'s $3.0M all-tracks total breaks down
Visby Medical, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
21/100
Total payments
F
38/100
Transaction volume
F
11/100
Physician reach
F
10/100
Payment type diversity
F
23/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer visby-medical-inc Visby Medical, Inc.
$3.0M · #359/1,925 · 0.0% industry · PY2024
- TOT $3.0M
- RANK #359
- SHARE 0.0%
- TXN 187
- RCP 30
- CAT 2
- GEN $73.4K
- ΔGEN +$2.6K
- TOP1 27.2%
- PY 2024
Volume peers
Nearest volume peer: MicroPort Orthopedics Inc ($3.0M)
Visby Medical, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Visby Medical, Inc.'s CMS-reported General Payments increased by $2.6K (+3.7%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: VISBY MEDICAL, INC.PY2023: VISBY MEDICAL, INC.PY2024: Visby Medical, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $70,814.25
- PY2024
- $73,418.24
What the Data Shows for Visby Medical, Inc.
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Visby Medical, Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
The 2-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Consulting Fee" at $73.2K, accounting for 99.7% of this company's General Payments and 18 transactions.
General Payment Breakdown by Type
"Consulting Fee" leads Visby Medical, Inc.'s 2-category general-payment breakdown at $73.2K, 99.7% of the reported total.
How Visby Medical, Inc. divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $73.2K | 18 | 99.7% |
| Food and Beverage | $230.74 | 12 | 0.3% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $73,187.50 (99.7%) of $73,418.24 in this company's General Payments records across 17 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Visby Medical, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Richard J Whitley
$20,000.00 across 4 reported transactions
- 2
Angela M Caliendo
$20,000.00 across 4 reported transactions
- 3
Edward W Hook
$15,000.00 across 4 reported transactions
- 4
David Relman
$15,000.00 across 4 reported transactions
- 5
Jeffrey D Klausner
$3,187.50 across 2 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Visby Medical, Inc. ranks #359 of 1,925 by total payments (top 19% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #685 of 1,838 by HHI (top 37% most concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Osteoremedies, LLC : $396.8K total payments, HHI 2355
- Avertix Medical, Inc : $164.0K total payments, HHI 2352
- Ricoh USA, Inc. : $336.00 total payments, HHI 2347
- Human Regenerative Technologies : $64.8K total payments, HHI 2346
- Medical Microinstruments, Inc. : $113.0K total payments, HHI 2343
- Captiox LLC : $34.7K total payments, HHI 2342
- Visby Medical, Inc. (this company) : $73.4K total payments, HHI 2338
- RIWOspine, Inc. : $30.8K total payments, HHI 2333
- HAPPE Spine : $1.2K total payments, HHI 2328
- Perrigo Company plc : $55.8K total payments, HHI 2328
- Microline Surgical Inc : $45.6K total payments, HHI 2322
- Lazurite Inc. : $20.5K total payments, HHI 2322
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Visby Medical, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Visby Medical, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Visby Medical, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
LENSAR, Inc.
BioFire Diagnostics, LLC
Hologic Inc
Array Biopharma Inc
Hinge Health, Inc.
Put this to use
Visby Medical, Inc. ranks #359 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See where Visby Medical, Inc. sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Visby Medical, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.